Literature DB >> 18248627

Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells.

Ambrose Jong1, Chun-Hua Wu, Gregory M Shackleford, Kyung J Kwon-Chung, Yun C Chang, Han-Min Chen, Yannan Ouyang, Sheng-He Huang.   

Abstract

Pathogenic yeast Cryptococcus neoformans causes devastating cryptococcal meningoencephalitis. Our previous studies demonstrated that C. neoformans hyaluronic acid was required for invasion into human brain microvascular endothelial cells (HBMEC), which constitute the blood-brain barrier. In this report, we demonstrate that C. neoformans hyaluronic acid interacts with CD44 on HBMEC. Our results suggest that HBMEC CD44 is a primary receptor during C. neoformans infection, based on the following observations. First, anti-CD44 neutralizing antibody treatment was able to significantly reduce C. neoformans association with HBMEC. Second, C. neoformans association was considerably impaired using either CD44-knock-down HBMEC or C. neoformans hyaluronic acid-deficient strains. Third, overexpression of CD44 in HBMEC increased their association activity towards C. neoformans. Fourth, confocal microscopic images showed that CD44 was enriched at and around the C. neoformans association sites. Fifth, upon C. neoformans and HBMEC engagement, a subpopulation of CD44 and actin translocated to the host membrane rafts. Our results highlight the interactions between C. neoformans hyaluronic acid and host CD44 and the dynamic results of these interactions, which may represent events during the adhesion and entry of C. neoformans at HBMEC membrane rafts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248627     DOI: 10.1111/j.1462-5822.2008.01128.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  54 in total

1.  Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans.

Authors:  Kiem Vu; Babette Weksler; Ignacio Romero; Pierre-Olivier Couraud; Angie Gelli
Journal:  Eukaryot Cell       Date:  2009-09-18

Review 2.  Host cell invasion by medically important fungi.

Authors:  Donald C Sheppard; Scott G Filler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 3.  Virulence mechanisms and Cryptococcus neoformans pathogenesis.

Authors:  J Andrew Alspaugh
Journal:  Fungal Genet Biol       Date:  2014-09-23       Impact factor: 3.495

4.  Hyaluronan impairs the barrier integrity of brain microvascular endothelial cells through a CD44-dependent pathway.

Authors:  Abraham J Al-Ahmad; Ronak Patel; Sean P Palecek; Eric V Shusta
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-28       Impact factor: 6.200

5.  Cryptococci at the brain gate: break and enter or use a Trojan horse?

Authors:  Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-04-26       Impact factor: 14.808

Review 6.  Can host receptors for fungi be targeted for treatment of fungal infections?

Authors:  Scott G Filler
Journal:  Trends Microbiol       Date:  2013-06-21       Impact factor: 17.079

7.  Cryptococcus neoformans activates RhoGTPase proteins followed by protein kinase C, focal adhesion kinase, and ezrin to promote traversal across the blood-brain barrier.

Authors:  Jong-Chul Kim; Benjamin Crary; Yun C Chang; Kyung J Kwon-Chung; Kee J Kim
Journal:  J Biol Chem       Date:  2012-08-16       Impact factor: 5.157

8.  Titan cell production enhances the virulence of Cryptococcus neoformans.

Authors:  Juliet N Crabtree; Laura H Okagaki; Darin L Wiesner; Anna K Strain; Judith N Nielsen; Kirsten Nielsen
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

Review 9.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

10.  Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cells.

Authors:  Kiem Vu; Richard A Eigenheer; Brett S Phinney; Angie Gelli
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.